Search research articles
Contact Us
Filters
Showing results (41-50 of 103) with videos related to
Page
of 11
Sort By:
Scientific Reports
|
May 28, 2015
Ion adsorption-induced wetting transition in oil-water-mineral systems
Frieder Mugele, Bijoyendra Bera, Andrea Cavalli, et al.
Scientific Reports
|
November 20, 2025
Discovery of first-in-class inhibitors of the TRF1:TIN2 protein:protein interaction by fragment screening
Giacomo Casale, Manjuan Liu, Yann-Vaï Le Bihan, et al.
Molecular Cancer Therapeutics
|
March 17, 2007
A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation
Anthea Hardcastle, Peter Tomlin, Clair Norris, et al.
Journal of Biomolecular Screening
|
July 29, 2010
Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinase
Daniel G Hayward, Yvette Newbatt, Lisa Pickard, et al.
Oncotarget
|
May 14, 2015
Molecular mechanisms of human IRE1 activation through dimerization and ligand binding
Amar Joshi, Yvette Newbatt, P Craig McAndrew, et al.
Cancer Research
|
April 5, 2015
Rho kinase inhibitors block melanoma cell migration and inhibit metastasis
Amine Sadok, Afshan McCarthy, John Caldwell, et al.
Nucleic Acids Research
|
October 21, 2022
The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use
Albert A Antolin, Domenico Sanfelice, Alisa Crisp, et al.
Journal of Biomolecular Screening
|
November 10, 2012
Identification of autophosphorylation inhibitors of the inositol-requiring enzyme 1 alpha (IRE1α) by high-throughput screening using a DELFIA assay
Yvette Newbatt, Anthea Hardcastle, P Craig McAndrew, et al.
Plos One
|
February 15, 2019
Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response
Caitlin Murphy, Andrea Muscat, David Ashley, et al.
British Journal of Pharmacology
|
January 19, 2005
Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors
John R Atack, Peter H Hutson, Neil Collinson, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 103) with videos related to
Sort By:
Page
of 11
Scientific Reports
|
May 28, 2015
Ion adsorption-induced wetting transition in oil-water-mineral systems
Frieder Mugele, Bijoyendra Bera, Andrea Cavalli, et al.
Scientific Reports
|
November 20, 2025
Discovery of first-in-class inhibitors of the TRF1:TIN2 protein:protein interaction by fragment screening
Giacomo Casale, Manjuan Liu, Yann-Vaï Le Bihan, et al.
Molecular Cancer Therapeutics
|
March 17, 2007
A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation
Anthea Hardcastle, Peter Tomlin, Clair Norris, et al.
Journal of Biomolecular Screening
|
July 29, 2010
Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinase
Daniel G Hayward, Yvette Newbatt, Lisa Pickard, et al.
Oncotarget
|
May 14, 2015
Molecular mechanisms of human IRE1 activation through dimerization and ligand binding
Amar Joshi, Yvette Newbatt, P Craig McAndrew, et al.
Cancer Research
|
April 5, 2015
Rho kinase inhibitors block melanoma cell migration and inhibit metastasis
Amine Sadok, Afshan McCarthy, John Caldwell, et al.
Nucleic Acids Research
|
October 21, 2022
The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use
Albert A Antolin, Domenico Sanfelice, Alisa Crisp, et al.
Journal of Biomolecular Screening
|
November 10, 2012
Identification of autophosphorylation inhibitors of the inositol-requiring enzyme 1 alpha (IRE1α) by high-throughput screening using a DELFIA assay
Yvette Newbatt, Anthea Hardcastle, P Craig McAndrew, et al.
Plos One
|
February 15, 2019
Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial-Clinical outcomes and molecular determinants of response
Caitlin Murphy, Andrea Muscat, David Ashley, et al.
British Journal of Pharmacology
|
January 19, 2005
Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors
John R Atack, Peter H Hutson, Neil Collinson, et al.
Page
of 11